Endurant Capital Management’s Sanofi SNY Stock Holding History

Endurant Capital Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-424,490	Closed	-$21.3M	–	82
2021 Q4	$21.3M	Buy	424,490 +369,669	+674%	+$18.3M	5.13%	3
2021 Q3	$2.64M	Buy	+54,821	New	+$2.79M	0.6%	37
2021 Q2	–	Sell	-272,218	Closed	-$13.5M	–	76
2021 Q1	$13.5M	Buy	+272,218	New	+$13.1M	3.51%	6
2020 Q3	–	Sell	-99,869	Closed	-$5.1M	–	72
2020 Q2	$5.1M	Sell	99,869 -310,092	-76%	-$15.1M	0.28%	21
2020 Q1	$17.9M	Buy	+409,961	New	+$19.6M	8.12%	1
2019 Q4	–	Sell	-67,200	Closed	-$3.11M	–	66
2019 Q3	$3.11M	Sell	67,200 -53,414	-44%	-$2.3M	1.12%	22
2019 Q2	$5.22M	Buy	+120,614	New	+$5.13M	2.06%	22
2019 Q1	–	Sell	-81,401	Closed	-$3.53M	–	84
2018 Q4	$3.53M	Sell	81,401 -51,844	-39%	-$2.29M	1.87%	19
2018 Q3	$5.95M	Buy	+133,245	New	+$5.69M	2.65%	9
2015 Q1	–	Sell	-21,200	Closed	-$967K	–	103
2014 Q4	$967K	Buy	+21,200	New	+$1.03M	0.38%	67

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Endurant Capital Management's SNY Position: Q1 2022 in Review

Endurant Capital Management sold out of Sanofi (SNY) in Q1 2022, closing a stake of 424,490 shares — an estimated $21.3M sold.

Endurant Capital Management first reported a position in SNY in Q4 2014 and held it in 10 quarters. The position peaked at $21.3M in Q4 2021. 623 funds tracked by Wall St. Rank hold SNY as of Q1 2022.

Endurant Capital Management reported no remaining Sanofi position as of Q1 2022 after selling out during the quarter.
Endurant Capital Management sold 424,490 Sanofi shares in Q1 2022, an estimated $21.3M.
Endurant Capital Management first reported a position in Sanofi in Q4 2014 and held it in 10 quarters.
Endurant Capital Management's Sanofi position peaked at $21.3M in Q4 2021.
623 funds tracked by Wall St. Rank held Sanofi as of Q1 2022.

Based on Endurant Capital Management's 13F filing for Q1 2022, filed 16 May 2022.